. Author manuscript; available in PMC: 2011 Nov 3.

Published in final edited form as: Depress Anxiety. 2011 Feb 24;28(4):342–348. doi: 10.1002/da.20789

TABLE 3.

Predictors of treatment outcomes

		DY-BOCS

	Contam. (I)	Symmetry (I)	Int: Harm (S)	Int: Sex (I)	MFQ (I)	MFQ (S)	SCARED (I)
Age	0.27 (0.21)	−.04 (0.39)	.00 (.04)	0.20 (0.16)	0.13 (0.51)	−.08 (.06)	0.73 (0.75)
Sex	−0.84 (1.45)	−.72 (1.46)	−.21 (.20)	1.11 (1.09)	0.72 (3.01)	.33 (.42)	1.92 (4.76)
Medication	3.24 (0.92) ^***	−.15 (1.41)	−.07 (.30)	0.20 (1.28)	9.51 (1.93)^***	.65 (.19)^**	9.79 (3.85)^*
Anxiety D/O	−0.13 (2.70)	−1.81 (1.46)	.48 (.15)^**	−2.10 (0.67)^**	−8.79 (2.18)^***	.08 (.22)	−9.37 (6.15)
Depressive D/O	3.42 (2.02)⁺	.09 (1.93)	−.60 (.16)^***	1.85 (1.91)	3.99 (3.68)	−.30 (.32)	6.70 (9.23)
ADHD	−2.19 (1.13)⁺	−1.05 (0.62)⁺	.17 (.19)	−0.05 (1.22)	1.22 (2.47)	.62 (.26)^*	−6.73 (4.89)

Note (I) indicates that the association with the intercept parameter (i.e., symptom level at discharge) is being estimated; (S) indicates that the association with the slope parameter (i.e., rate of symptom reduction) is being estimated.

P<.05;

^**

P<.01;

^***

P<.001.